Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

IPOs
News

Torrid Holdings Shares Expected To Open For Trade Today; IPO Priced At $21/Share

(NYSE:CURV)

byMichael Horton

July 1, 2021

1 minute read

(NYSE:CURV)

ImmunoGen’s Newly Approved Ovarian Cancer Drug Listed As Preferred Regime

By Vandana Singh

Today, 10:08 PM

The National Comprehensive Cancer Network (NCCN) released new guidelines for ovarian cancer treatment, which include ImmunoGen Inc's (NASDAQ: IMGN) Elahere (mirvetuximab soravtansine-gynx) as a preferred regimen.

IMGN

PayPal And 3 Other Stocks Insiders Are Selling

By Lisa Levin

Today, 10:08 PM

Gold futures traded slightly higher on Tuesday. Investors, meanwhile, focused on some notable insider trades.

ABNB

BTIG Initiates Coverage On CTI BioPharma with Buy Rating, Announces Price Target of $7

By Benzinga Newsdesk

Today, 10:08 PM

BTIG analyst Robert Hazlett initiates coverage on CTI BioPharma (NASDAQ:CTIC) with a Buy rating and announces Price Target of $7.

CTIC

Truist Remains Bullish On Lightspeed Commerce, Naming It An Acquisition Target; Credit Suisse Downgrades The Stock

By Anusuya Lahiri

Today, 10:08 PM

Credit Suisse analyst Timothy Chiodo downgraded Lightspeed Commerce Inc (NYSE:LSPD) from Outperform to Neutral and lowered the price target from $21 to…

LSPD

Torrid Holdings Shares Expected To Open For Trade Today; IPO Priced At $21/Share

Related Posts

ImmunoGen’s Newly Approved Ovarian Cancer Drug Listed As Preferred Regime

PayPal And 3 Other Stocks Insiders Are Selling

BTIG Initiates Coverage On CTI BioPharma with Buy Rating, Announces Price Target of $7

Truist Remains Bullish On Lightspeed Commerce, Naming It An Acquisition Target; Credit Suisse Downgrades The Stock